Hereditary Angioedema Market Scope And Analysis

  • Report Code : TIPRE00005410
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Hereditary Angioedema Market Analysis and Growth - 2031

Buy Now

Hereditary Angioedema Market Report Hereditary Angioedema Market Size and Share Hereditary Angioedema Market Scope and Analysis

Hereditary Angioedema Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Drugs
  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Bradykinin Receptor
  • Attenuated Androgens
By Route of Administration
  • Subcutaneous
  • Intravenous
  • Oral
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BIOCRYST PHARMACEUTICALS INC
  • CSL
  • Ionis Pharmaceuticals Inc
  • Merck Sharp Dohme Corp
  • Pharming Group N V
  • Sanofi N V
  • Shire plc
  • Teva Pharmaceutical Industries Ltd
  • Attune Pharmaceuticals